Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 8 | 2024 | 5256 | 0.820 |
Why?
|
| Adenocarcinoma | 9 | 2024 | 6364 | 0.820 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2016 | 101 | 0.640 |
Why?
|
| Gastroenterology | 2 | 2021 | 536 | 0.630 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2024 | 1634 | 0.590 |
Why?
|
| Hospitalists | 1 | 2021 | 305 | 0.580 |
Why?
|
| CA-19-9 Antigen | 3 | 2024 | 111 | 0.470 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 504 | 0.430 |
Why?
|
| Barrett Esophagus | 3 | 2023 | 494 | 0.420 |
Why?
|
| Pancreas | 4 | 2024 | 1686 | 0.410 |
Why?
|
| Carcinoma in Situ | 2 | 2016 | 806 | 0.380 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 3086 | 0.370 |
Why?
|
| Cecum | 1 | 2010 | 237 | 0.360 |
Why?
|
| Esophagogastric Junction | 1 | 2010 | 313 | 0.320 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 222 | 0.320 |
Why?
|
| Stomach Neoplasms | 2 | 2015 | 1333 | 0.260 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 975 | 0.240 |
Why?
|
| Carcinoma | 1 | 2016 | 2375 | 0.240 |
Why?
|
| Telomere | 2 | 2020 | 910 | 0.230 |
Why?
|
| Ambulatory Care | 3 | 2021 | 2708 | 0.190 |
Why?
|
| Gallbladder Diseases | 1 | 2021 | 125 | 0.180 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 1583 | 0.180 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6234 | 0.170 |
Why?
|
| Endosonography | 3 | 2021 | 610 | 0.160 |
Why?
|
| Stents | 1 | 2010 | 3280 | 0.160 |
Why?
|
| Colonoscopy | 4 | 2022 | 1367 | 0.160 |
Why?
|
| Telangiectasis | 1 | 2018 | 76 | 0.160 |
Why?
|
| Pancreatitis, Chronic | 2 | 2020 | 285 | 0.150 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 635 | 0.140 |
Why?
|
| Gastric Fistula | 1 | 2017 | 73 | 0.140 |
Why?
|
| Intestinal Fistula | 1 | 2017 | 140 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 11031 | 0.140 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2016 | 50 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 441 | 0.130 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 6773 | 0.130 |
Why?
|
| Arteriovenous Fistula | 1 | 2018 | 315 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 814 | 0.130 |
Why?
|
| Medication Errors | 1 | 2021 | 798 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20129 | 0.110 |
Why?
|
| Pancreatic Ducts | 1 | 2015 | 328 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 1130 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1162 | 0.110 |
Why?
|
| Natural Language Processing | 1 | 2021 | 1041 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1170 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2018 | 761 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 9239 | 0.100 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2016 | 379 | 0.100 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 1164 | 0.100 |
Why?
|
| Endoscopy | 1 | 2021 | 1785 | 0.090 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2015 | 388 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1094 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 1912 | 0.090 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2009 | 15 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2021 | 2151 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
| Mass Screening | 2 | 2022 | 5255 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2017 | 812 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3567 | 0.080 |
Why?
|
| Humans | 25 | 2024 | 744343 | 0.080 |
Why?
|
| Genomics | 2 | 2023 | 5720 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2022 | 3749 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1213 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 4851 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5137 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 8089 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9687 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6544 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2023 | 184 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9438 | 0.050 |
Why?
|
| Metaplasia | 1 | 2021 | 313 | 0.050 |
Why?
|
| Central Nervous System Cysts | 1 | 2020 | 58 | 0.050 |
Why?
|
| Dyskeratosis Congenita | 1 | 2020 | 72 | 0.040 |
Why?
|
| Gallbladder | 1 | 2021 | 302 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 154 | 0.040 |
Why?
|
| Deep Sedation | 1 | 2021 | 121 | 0.040 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2021 | 195 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 304 | 0.040 |
Why?
|
| Adult | 9 | 2021 | 214055 | 0.040 |
Why?
|
| Telephone | 1 | 2021 | 617 | 0.040 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 238 | 0.040 |
Why?
|
| Male | 12 | 2023 | 350118 | 0.040 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2017 | 87 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 2020 | 368 | 0.040 |
Why?
|
| Office Visits | 1 | 2021 | 598 | 0.040 |
Why?
|
| Jejunal Diseases | 1 | 2017 | 50 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 570 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 417 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2021 | 528 | 0.030 |
Why?
|
| Microcephaly | 1 | 2020 | 432 | 0.030 |
Why?
|
| Thorax | 1 | 2019 | 547 | 0.030 |
Why?
|
| Aged | 8 | 2021 | 163280 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 903 | 0.030 |
Why?
|
| Drainage | 1 | 2021 | 1142 | 0.030 |
Why?
|
| Female | 11 | 2021 | 380194 | 0.030 |
Why?
|
| Ulcer | 1 | 2017 | 209 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 933 | 0.030 |
Why?
|
| Middle Aged | 9 | 2021 | 213383 | 0.030 |
Why?
|
| Education | 1 | 2018 | 543 | 0.030 |
Why?
|
| Metabolomics | 1 | 2023 | 1484 | 0.030 |
Why?
|
| Disease Progression | 2 | 2023 | 13284 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1341 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
| Retinal Diseases | 1 | 2020 | 683 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2016 | 390 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 345 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1184 | 0.030 |
Why?
|
| Prostate | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Colectomy | 1 | 2018 | 683 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11366 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 673 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 4186 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2021 | 2504 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 57776 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 789 | 0.030 |
Why?
|
| Calcinosis | 1 | 2020 | 1499 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1526 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2019 | 2488 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2015 | 663 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1788 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2948 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2024 | 4286 | 0.020 |
Why?
|
| Diarrhea | 1 | 2017 | 1348 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
| Retina | 1 | 2020 | 2616 | 0.020 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2009 | 22 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2009 | 49 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9849 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2009 | 141 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2046 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2859 | 0.020 |
Why?
|
| Risk Factors | 3 | 2021 | 72290 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2541 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7785 | 0.020 |
Why?
|
| Mutation | 2 | 2021 | 29786 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2250 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12959 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77449 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 506 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20947 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 783 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16365 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2016 | 40561 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2758 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 85781 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 8863 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12720 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 41006 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40075 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5985 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13102 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15295 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
| Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168757 | 0.000 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_